nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—AKR1B1—cardiovascular system—nicotine dependence	0.0398	0.141	CbGeAlD
Sulindac—PTGDR2—brain—nicotine dependence	0.0368	0.13	CbGeAlD
Sulindac—AKR1B1—midbrain—nicotine dependence	0.0311	0.11	CbGeAlD
Sulindac—MAPK3—cardiovascular system—nicotine dependence	0.0289	0.102	CbGeAlD
Sulindac—PPARD—midbrain—nicotine dependence	0.0245	0.0863	CbGeAlD
Sulindac—MAPK3—midbrain—nicotine dependence	0.0226	0.0796	CbGeAlD
Sulindac—AKR1B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0206	0.0725	CbGpPWpGaD
Sulindac—AKR1B1—brain—nicotine dependence	0.0196	0.069	CbGeAlD
Sulindac—AKR1B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0191	0.0674	CbGpPWpGaD
Sulindac—Nephrolithiasis—Varenicline—nicotine dependence	0.0188	0.0434	CcSEcCtD
Sulindac—Tenderness—Varenicline—nicotine dependence	0.0173	0.04	CcSEcCtD
Sulindac—Leukocytosis—Varenicline—nicotine dependence	0.0161	0.0372	CcSEcCtD
Sulindac—PPARD—brain—nicotine dependence	0.0154	0.0542	CbGeAlD
Sulindac—PTGDR2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0151	0.0532	CbGpPWpGaD
Sulindac—Hyperkalaemia—Varenicline—nicotine dependence	0.0148	0.0343	CcSEcCtD
Sulindac—MAPK3—brain—nicotine dependence	0.0142	0.05	CbGeAlD
Sulindac—Visual disturbance—Varenicline—nicotine dependence	0.0116	0.0267	CcSEcCtD
Sulindac—Arthritis—Varenicline—nicotine dependence	0.0113	0.0261	CcSEcCtD
Sulindac—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.011	0.0253	CcSEcCtD
Sulindac—SLC22A6—brain—nicotine dependence	0.0108	0.0382	CbGeAlD
Sulindac—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.0106	0.0373	CbGpPWpGaD
Sulindac—Gastritis—Varenicline—nicotine dependence	0.0097	0.0224	CcSEcCtD
Sulindac—PTGDR2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00916	0.0322	CbGpPWpGaD
Sulindac—Photosensitivity reaction—Varenicline—nicotine dependence	0.00865	0.02	CcSEcCtD
Sulindac—Hyperglycaemia—Varenicline—nicotine dependence	0.00854	0.0198	CcSEcCtD
Sulindac—Depression—Varenicline—nicotine dependence	0.00842	0.0195	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00837	0.0194	CcSEcCtD
Sulindac—Stomatitis—Varenicline—nicotine dependence	0.00823	0.019	CcSEcCtD
Sulindac—Conjunctivitis—Varenicline—nicotine dependence	0.00821	0.019	CcSEcCtD
Sulindac—Epistaxis—Varenicline—nicotine dependence	0.00797	0.0184	CcSEcCtD
Sulindac—PTGS1—cardiovascular system—nicotine dependence	0.00785	0.0277	CbGeAlD
Sulindac—PTGS2—cardiovascular system—nicotine dependence	0.0075	0.0265	CbGeAlD
Sulindac—Visual impairment—Varenicline—nicotine dependence	0.00731	0.0169	CcSEcCtD
Sulindac—Erythema multiforme—Varenicline—nicotine dependence	0.00717	0.0166	CcSEcCtD
Sulindac—Tinnitus—Varenicline—nicotine dependence	0.00707	0.0163	CcSEcCtD
Sulindac—Chills—Varenicline—nicotine dependence	0.0068	0.0157	CcSEcCtD
Sulindac—Arrhythmia—Varenicline—nicotine dependence	0.00677	0.0157	CcSEcCtD
Sulindac—ALB—brain—nicotine dependence	0.00676	0.0238	CbGeAlD
Sulindac—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00676	0.0238	CbGpPWpGaD
Sulindac—MAPK3—Regulation of actin dynamics for phagocytic cup formation—WASF2—nicotine dependence	0.00658	0.0232	CbGpPWpGaD
Sulindac—MAPK3—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.00652	0.023	CbGpPWpGaD
Sulindac—Flatulence—Varenicline—nicotine dependence	0.0065	0.015	CcSEcCtD
Sulindac—Dysgeusia—Varenicline—nicotine dependence	0.00646	0.0149	CcSEcCtD
Sulindac—PTGDR2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00638	0.0224	CbGpPWpGaD
Sulindac—MAPK3—Regulation of actin dynamics for phagocytic cup formation—WASF1—nicotine dependence	0.00631	0.0222	CbGpPWpGaD
Sulindac—Vision blurred—Varenicline—nicotine dependence	0.00622	0.0144	CcSEcCtD
Sulindac—Ill-defined disorder—Varenicline—nicotine dependence	0.00612	0.0142	CcSEcCtD
Sulindac—Anaemia—Varenicline—nicotine dependence	0.0061	0.0141	CcSEcCtD
Sulindac—Angioedema—Varenicline—nicotine dependence	0.00603	0.0139	CcSEcCtD
Sulindac—Malaise—Varenicline—nicotine dependence	0.00595	0.0138	CcSEcCtD
Sulindac—Vertigo—Varenicline—nicotine dependence	0.00593	0.0137	CcSEcCtD
Sulindac—Syncope—Varenicline—nicotine dependence	0.00592	0.0137	CcSEcCtD
Sulindac—PTGDR2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00592	0.0208	CbGpPWpGaD
Sulindac—PTGS2—midbrain—nicotine dependence	0.00586	0.0207	CbGeAlD
Sulindac—Palpitations—Varenicline—nicotine dependence	0.00583	0.0135	CcSEcCtD
Sulindac—Loss of consciousness—Varenicline—nicotine dependence	0.0058	0.0134	CcSEcCtD
Sulindac—Convulsion—Varenicline—nicotine dependence	0.00572	0.0132	CcSEcCtD
Sulindac—Hypertension—Varenicline—nicotine dependence	0.0057	0.0132	CcSEcCtD
Sulindac—Myalgia—Varenicline—nicotine dependence	0.00562	0.013	CcSEcCtD
Sulindac—Arthralgia—Varenicline—nicotine dependence	0.00562	0.013	CcSEcCtD
Sulindac—Chest pain—Varenicline—nicotine dependence	0.00562	0.013	CcSEcCtD
Sulindac—Discomfort—Varenicline—nicotine dependence	0.00555	0.0128	CcSEcCtD
Sulindac—Oedema—Varenicline—nicotine dependence	0.00539	0.0125	CcSEcCtD
Sulindac—Shock—Varenicline—nicotine dependence	0.0053	0.0123	CcSEcCtD
Sulindac—Thrombocytopenia—Varenicline—nicotine dependence	0.00527	0.0122	CcSEcCtD
Sulindac—Tachycardia—Varenicline—nicotine dependence	0.00526	0.0122	CcSEcCtD
Sulindac—Hyperhidrosis—Varenicline—nicotine dependence	0.00521	0.012	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00517	0.0182	CbGpPWpGaD
Sulindac—Anorexia—Varenicline—nicotine dependence	0.00513	0.0119	CcSEcCtD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00507	0.0178	CbGpPWpGaD
Sulindac—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00506	0.0178	CbGpPWpGaD
Sulindac—Hypotension—Varenicline—nicotine dependence	0.00503	0.0116	CcSEcCtD
Sulindac—MAPK3—Fcgamma receptor (FCGR) dependent phagocytosis—WASF2—nicotine dependence	0.00497	0.0175	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00491	0.0113	CcSEcCtD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0049	0.0173	CbGpPWpGaD
Sulindac—Insomnia—Varenicline—nicotine dependence	0.00487	0.0113	CcSEcCtD
Sulindac—Dyspnoea—Varenicline—nicotine dependence	0.0048	0.0111	CcSEcCtD
Sulindac—Somnolence—Varenicline—nicotine dependence	0.00479	0.0111	CcSEcCtD
Sulindac—MAPK3—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.00476	0.0168	CbGpPWpGaD
Sulindac—Dyspepsia—Varenicline—nicotine dependence	0.00474	0.011	CcSEcCtD
Sulindac—PTGDR2—Signaling by GPCR—TAS2R16—nicotine dependence	0.0047	0.0165	CbGpPWpGaD
Sulindac—Decreased appetite—Varenicline—nicotine dependence	0.00468	0.0108	CcSEcCtD
Sulindac—Fatigue—Varenicline—nicotine dependence	0.00464	0.0107	CcSEcCtD
Sulindac—PTGDR2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00461	0.0162	CbGpPWpGaD
Sulindac—Constipation—Varenicline—nicotine dependence	0.00461	0.0107	CcSEcCtD
Sulindac—Feeling abnormal—Varenicline—nicotine dependence	0.00444	0.0103	CcSEcCtD
Sulindac—Gastrointestinal pain—Varenicline—nicotine dependence	0.0044	0.0102	CcSEcCtD
Sulindac—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0044	0.0155	CbGpPWpGaD
Sulindac—CYP1A1—brain—nicotine dependence	0.00438	0.0155	CbGeAlD
Sulindac—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00434	0.0153	CbGpPWpGaD
Sulindac—Urticaria—Varenicline—nicotine dependence	0.00428	0.0099	CcSEcCtD
Sulindac—PTGDR2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00428	0.0151	CbGpPWpGaD
Sulindac—Body temperature increased—Varenicline—nicotine dependence	0.00426	0.00985	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—FGD1—nicotine dependence	0.00406	0.0143	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00404	0.0142	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00398	0.014	CbGpPWpGaD
Sulindac—Hypersensitivity—Varenicline—nicotine dependence	0.00397	0.00918	CcSEcCtD
Sulindac—MAPK3—TCR Signaling Pathway—OPRM1—nicotine dependence	0.00394	0.0139	CbGpPWpGaD
Sulindac—Asthenia—Varenicline—nicotine dependence	0.00386	0.00894	CcSEcCtD
Sulindac—PTGDR2—GPCR ligand binding—OPRM1—nicotine dependence	0.00386	0.0136	CbGpPWpGaD
Sulindac—PTGS1—brain—nicotine dependence	0.00385	0.0136	CbGeAlD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00381	0.0134	CbGpPWpGaD
Sulindac—Pruritus—Varenicline—nicotine dependence	0.00381	0.00881	CcSEcCtD
Sulindac—MAPK3—Signaling by VEGF—WASF2—nicotine dependence	0.00375	0.0132	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—FGD1—nicotine dependence	0.00369	0.013	CbGpPWpGaD
Sulindac—Diarrhoea—Varenicline—nicotine dependence	0.00369	0.00852	CcSEcCtD
Sulindac—PTGS2—brain—nicotine dependence	0.00368	0.013	CbGeAlD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00366	0.0129	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—WASF1—nicotine dependence	0.0036	0.0127	CbGpPWpGaD
Sulindac—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00357	0.0126	CbGpPWpGaD
Sulindac—Dizziness—Varenicline—nicotine dependence	0.00356	0.00824	CcSEcCtD
Sulindac—MAPK3—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00351	0.0124	CbGpPWpGaD
Sulindac—Vomiting—Varenicline—nicotine dependence	0.00342	0.00792	CcSEcCtD
Sulindac—Rash—Varenicline—nicotine dependence	0.0034	0.00785	CcSEcCtD
Sulindac—Dermatitis—Varenicline—nicotine dependence	0.00339	0.00785	CcSEcCtD
Sulindac—Headache—Varenicline—nicotine dependence	0.00337	0.0078	CcSEcCtD
Sulindac—AKR1B1—Metabolism—CYP2A7—nicotine dependence	0.00332	0.0117	CbGpPWpGaD
Sulindac—Nausea—Varenicline—nicotine dependence	0.0032	0.0074	CcSEcCtD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00305	0.0107	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00293	0.0103	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGD1—nicotine dependence	0.00291	0.0102	CbGpPWpGaD
Sulindac—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00281	0.00988	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—DRD2—nicotine dependence	0.00279	0.00983	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TAS2R16—nicotine dependence	0.00278	0.00977	CbGpPWpGaD
Sulindac—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00277	0.00975	CbGpPWpGaD
Sulindac—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00269	0.00947	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—CCAR1—nicotine dependence	0.0024	0.00845	CbGpPWpGaD
Sulindac—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00227	0.00801	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00218	0.00768	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGD1—nicotine dependence	0.00218	0.00767	CbGpPWpGaD
Sulindac—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00201	0.00708	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—OPRM1—nicotine dependence	0.00198	0.00698	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AKR1B10—nicotine dependence	0.00192	0.00677	CbGpPWpGaD
Sulindac—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00189	0.00667	CbGpPWpGaD
Sulindac—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00187	0.00658	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—DRD2—nicotine dependence	0.00158	0.00555	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—DRD2—nicotine dependence	0.00143	0.00504	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—WASF2—nicotine dependence	0.00136	0.00477	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00135	0.00475	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—WASF1—nicotine dependence	0.0013	0.00458	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00128	0.00451	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—CCAR1—nicotine dependence	0.00123	0.00431	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00121	0.00427	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00121	0.00425	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CYP2A7—nicotine dependence	0.0012	0.00423	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00119	0.0042	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—OPRM1—nicotine dependence	0.00117	0.00412	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—FGD1—nicotine dependence	0.00106	0.00373	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—WASF2—nicotine dependence	0.00103	0.00364	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—WASF1—nicotine dependence	0.00099	0.00349	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—DRD2—nicotine dependence	0.000846	0.00298	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TAS2R16—nicotine dependence	0.000797	0.0028	CbGpPWpGaD
Sulindac—MAPK3—Disease—AKR1B10—nicotine dependence	0.000789	0.00278	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000631	0.00222	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGD1—nicotine dependence	0.000625	0.0022	CbGpPWpGaD
Sulindac—MAPK3—Immune System—WASF2—nicotine dependence	0.000602	0.00212	CbGpPWpGaD
Sulindac—MAPK3—Immune System—WASF1—nicotine dependence	0.000577	0.00203	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—OPRM1—nicotine dependence	0.000568	0.002	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKR1B10—nicotine dependence	0.000552	0.00194	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKR1B10—nicotine dependence	0.000469	0.00165	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.00046	0.00162	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—DRD2—nicotine dependence	0.000411	0.00145	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—WASF2—nicotine dependence	0.000389	0.00137	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—WASF1—nicotine dependence	0.000373	0.00131	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP2A7—nicotine dependence	0.000365	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—OPRM1—nicotine dependence	0.000336	0.00118	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000324	0.00114	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP2A7—nicotine dependence	0.000295	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—DRD2—nicotine dependence	0.000243	0.000855	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000207	0.000727	CbGpPWpGaD
